Aspaveli
pegcetacoplan
Hemoglobinuria, Paroxysmal
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanAuthorised
Fabhalta
Iptacopan
Hemoglobinuria, Paroxysmal
Opinion date:
Last updated:
MedicineHumanOpinion
Epysqli
Hemoglobinuria, Paroxysmal
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Voydeya
Danicopan
Hemoglobinuria, Paroxysmal
Hemolysis
Opinion date:
Last updated:
MedicineHumanOpinion
Bekemv
eculizumab
Hemoglobinuria, Paroxysmal
Date of authorisation:
Revision: 2
Last updated:
MedicineHumanAuthorised
Soliris
eculizumab
Hemoglobinuria, Paroxysmal
Date of authorisation:
Revision: 36
Last updated:
MedicineHumanAuthorised
EMEA-002600-PIP04-22 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Neurology
PIP number: P/0403/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ultomiris
ravulizumab
Hemoglobinuria, Paroxysmal
Date of authorisation:
Revision: 13
Last updated:
MedicineHumanAuthorised
EMEA-002600-PIP03-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Uro-nephrology
PIP number: P/0284/2022
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman